Erdanib

Erdanib uses and dosage

Erdanib (Erdafitinib), generic Balversa is a prescription medicine used to treat adult patients with locally advanced or metastatic Urothelial Carcinoma (bladder cancer) that has susceptible FGFR3 or FGFR2 genetic alterations and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy. Erdanib is manufactured by Drug International Pharma Ltd. In Bangladesh. Erdafitinib has to take orally once daily with or without food.

Erdanib side effects

The most common adverse reactions of Erdafitinib are: Nausea, vomiting, mouth sores/pain, change in how food tastes, abdominal pain, diarrhea, constipation, loss of appetite, weight loss, tiredness, dry mouth/skin, or muscle/joint pain.

Originator brand

Balversa by Janssen

Made by

Drug International Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.